Tempus Completes Acquisition of Ambry Genetics

4 days ago · Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its …

CouponFollow Extension

$600
OFF

Tempus AI Acquires Ambry Genetics In $600M Strategic …

2 weeks from now

3 days ago · Tempus AI expands diagnostic capabilities with $600M acquisition of Ambry Genetics, combining advanced testing and data analytics to enhance healthcare solutions for …

stocktitan.net

$600
OFF

Tempus AI, Inc Completed The Acquisition Of Ambry Genetics …

2 weeks from now

2 days ago · Tempus AI, Inc agreed to acquire Ambry Genetics Corporation from REALM IDx, Inc. for approximately $600 million on November 4, 2024. Pursuant to the terms of the Purchase …

marketscreener.com

$600
OFF

Tempus AI Acquires Ambry Genetics For $600 Million

2 weeks from now

Nov 11, 2024 · Tempus AI said it has entered into an agreement to acquire Ambry Genetics, a company specializing in genetic testing. Under the terms of the agreement, Tempus will pay …

medicaldesigndevelopment.com

$600
OFF

Tempus Expects $600M Ambry Genetics Acquisition To Accelerate …

2 weeks from now

Note: This story has been updated to note that Ambry is owned by Konica Minolta. NEW YORK – Tempus AI's $600 million acquisition of Ambry Genetics is expected to accelerate the …

360dx.com

$600
OFF

Tempus AI (TEM) Acquires Ambry Genetics In $600M Precision …

2 weeks from now

We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other top AI …

yahoo.com

$600
OFF

Tempus AI Shakes Up Precision Medicine With $600m Acquisition …

2 weeks from now

Nov 5, 2024 · Tempus AI has taken a significant step in advancing its precision medicine strategy by agreeing to acquire Ambry Genetics in a $600 million deal. This move, comprising $375 …

business-news-today.com

$600
OFF

Tempus AI To Acquire Ambry Genetics For $600 Million, Expanding …

2 weeks from now

Nov 5, 2024 · Tempus AI has agreed to acquire Ambry Genetics, a genetic testing company, for $600 million—$375 million in cash and $225 million in Tempus shares. Ambry, which conducts …

nextedge.in

$600
OFF

Tempus AI To Acquire Ambry Genetics For $600 Million

2 weeks from now

Nov 11, 2024 · Tempus AI has announced its acquisition of Ambry Genetics, from KONICA MINOLTA, INC. for $600 million, comprising $375 million in cash and $225 million in shares. …

platohealth.ai

$74
OFF

Why Tempus AI Inc. (TEM) Went Up On Wednesday - Yahoo Finance

2 weeks from now

21 hours ago · On Wednesday, TD Cowen reiterated its buy rating for Tempus AI’s shares, while increasing the price target to $74 after the company successfully closed its acquisition of …

yahoo.com

$600
OFF

Ambry Genetics Being Acquired By Tempus AI For $600M

2 weeks from now

Nov 6, 2024 · Aliso Viejo-based Ambry Genetics Corp., Orange County’s third-largest medical diagnostics and testing company, has entered into an agreement to be acquired for $600 …

healthcaredealflow.com

$600
OFF

Tempus AI Completes Acquisition Of Ambry Genetics To Advance …

2 weeks from now

2 days ago · Highlights,Acquisition Deal Finalized:,Tempus AI acquired,Ambry Genetics,for,$600 million,in cash and stock.,Strategic Expansion:,The deal strengthens Tempus’ role in,AI-driven …

kalkinemedia.com

5%
OFF

Tempus AI Shares Rise 5% Pre-market On Continued Momentum, …

2 weeks from now

2 days ago · Investing.com -- Shares of Tempus AI , Inc. (NASDAQ: TEM) climbed 5% in pre-open trading Tuesday following the completion of its acquisition of Ambry Genetics, a …

investing.com

FAQs about Tempus Completes Acquisition of Ambry Genetics Coupon?

Did Tempus AI buy Ambry Genetics?

Courtesy of Ambry Genetics Tempus AI agreed to buy genetic testing company Ambry Genetics for $375 million in cash and $225 million in shares. Chicago-based Tempus, which makes AI-enabled precision medicine solutions, said the purchase will provide expanded testing capabilities for inherited cancer risk. ...

Why did Tempus buy ambry?

The purchase of Ambry follows Tempus' acquisition of SEngine Precision Medicine, founded by Dr. Carla Grandori, which brought in an organoid biobank and PARIS testing platform. These recent acquisitions indicate Tempus’ strategic expansion into the immunotherapy testing space in precision medicine. ...

Will Tempus Ai be acquired?

We have entered into a definitive agreement to be acquired by Tempus AI, a company advancing precision medicine through the practical application of artificial intelligence in healthcare. We anticipate the acquisition to officially close in the first quarter of 2025 and look forward to empowering our shared goal of improving patient outcomes. ...

What did Tempus CEO Eric Lefkofsky say about ambry?

Tempus CEO Eric Lefkofsky highlighted Ambry’s revenue growth, which exceeds 25% annually, and its strong EBITDA and cash flow contributions. Tempus AI has agreed to acquire Ambry Genetics, a genetic testing company, for $600 million—$375 million in cash and $225 million in Tempus shares. ...

How much will Tempus pay for ambry?

Tempus will pay $600 million in total consideration for Ambry — $375 million in cash and $225 million in equity over the next year. The company will finance the deal through a $300 million increase in short- and long-term debt. ...

Should TD Cowen buy Tempus AI?

On Wednesday, TD Cowen reiterated its buy rating for Tempus AI’s shares, while increasing the price target to $74 after the company successfully closed its acquisition of Ambry Genetics, a deal that the investment research firm believes would position the company for more product offerings and entry into new markets. ...